Laura O. Moran

Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 27, 2025

SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 10, 2024

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

Journal: Haematologica

Published: July 01, 2024

Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.

Journal: European journal of internal medicine

Published: April 22, 2022

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 09, 2022

Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 07, 2020

Pharmacological cancer treatment and venous thromboembolism risk.

Journal: European heart journal supplements : journal of the European Society of Cardiology

Published: May 06, 2020

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.

Journal: Frontiers in immunology

Published: October 30, 2018

Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis.

Comparative analysis of risk prediction scores including all types of cancer-associated thrombosis.

SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

Cancer-related thrombosis: impact of biological sex on the risk of rethrombosis and bleeding.

Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.

Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).

Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).

Pharmacological cancer treatment and venous thromboembolism risk.

Pharmacological cancer treatment and venous thromboembolism risk.

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation.

Early mortality after heart transplantation related to IgA anti-β2-glycoprotein I antibodies.

Early mortality after heart transplantation related to IgA anti-β2-glycoprotein I antibodies.

An unusual case of cardiomegaly.

An unusual case of cardiomegaly.